Target intelligence / Profile preview

Long non-coding RNA for programmed cell death 5 and p53 stability (LNPPS)

Target
LNPPS
Molecular classification
Long non-coding RNA, Scaffold lncRNA, Other
01

Overview

Long non-coding RNA for programmed cell death 5 and p53 stability (LNPPS) is a long non-coding RNA transcript (ENST00000622374) discovered in the context of bladder cancer. LNPPS acts as a scaffold, physically connecting PDCD5 and the tumor suppressor protein p53 via distinct nucleotide regions, thereby enhancing their interaction. This lncRNA protects PDCD5 from proteasomal degradation by masking its ubiquitination at K20, and disrupts MDM2-mediated ubiquitination of p53, increasing p53 stability and promoting apoptosis. LNPPS is typically downregulated in bladder cancer tissues due to reduced N6-methyladenosine (m6A) modification, contributing to tumor survival. Restoration or enhancement of LNPPS expression in cancer cells leads to upregulation of p53 and activation of apoptosis pathways, marking it as a potent tumor suppressor and a potential therapeutic target for bladder cancer and possibly other malignancies where the PDCD5/p53 axis plays a role[1][3].

Other names
LNPPSlncRNA PDCD5 and p53 scaffolda lncRNA for programmed cell death 5 (PDCD5) and p53 stability
02

Mechanism of action

Scaffold-mediated inhibition of ubiquitination (prevents PDCD5 ubiquitination at K20, impairs MDM2-mediated ubiquitination of p53), Stabilization of p53 and PDCD5, Activation of p53-dependent apoptosis

03

Biological functions

Regulation of apoptosisRegulation of protein stabilityScaffold for protein-protein interactionsRegulation of ubiquitinationNuclear translocation facilitatorTumor suppressor activity
04

Disease associations

Cancer (notably bladder cancer)Tumor suppression
05

Safety considerations

Not establishedas a long non-coding RNA, direct therapeutic targeting would require caution due to possible effects on global RNA processing or stability
06

Biomarkers

Downregulation of LNPPS in bladder cancer tissue may serve as a biomarkerincreased levels correlate with apoptosis-related gene expression

Beyond the preview

Go deeper on Long non-coding RNA for programmed cell death 5 and p53 stability (LNPPS).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long non-coding RNA for programmed cell death 5 and p53 stability (LNPPS).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call